Treatment of endotoxemic mice with anti-interleukin-6 antibody paradoxically increases interleukin-6 levels and stimulates mucosal protein synthesis

Arch Surg. 1997 Jan;132(1):82-8. doi: 10.1001/archsurg.1997.01430250084018.

Abstract

Objective: To test the role of interleukin-6 (IL-6) in the regulation of mucosal protein synthesis during endotoxemia.

Experimental design: Three series of experiments were performed: (1) mice were injected with different doses of lipopolysaccharide (LPS) and protein synthesis was measured in jejunal mucosa at various time points up to 24 hours after injection of LPS; (2) mice were pretreated with anti-IL-6 antibody before injection of LPS; and (3) mice were injected with recombinant IL-6 and mucosal protein synthesis was measured 24 hours later.

Results: Treatment of mice with LPS resulted in a dose- and time-dependent increase in mucosal protein synthesis. Pretreatment of endotoxemic mice with anti-IL-6 antibody resulted in a paradoxical increase in plasma and tissue levels of IL-6 and a further increase in mucosal protein synthesis. Administration of IL-6 to normal mice resulted in increased mucosal protein synthesis.

Conclusion: The increase in mucosal protein synthesis seen during endotoxemia may be regulated at least in part by IL-6.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / administration & dosage*
  • Dose-Response Relationship, Drug
  • Endotoxemia / metabolism*
  • Interleukin-6 / analysis
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / immunology
  • Intestinal Mucosa / metabolism*
  • Male
  • Mice
  • Mice, Inbred A
  • Protein Biosynthesis*

Substances

  • Antibodies
  • Interleukin-6